Target intelligence / Profile preview

Kelch-like protein 28 (KLHL28)

Target
KLHL28
Molecular classification
Other (Kelch-like protein family), Adapter protein (for CUL3-RING E3 ligase complex), BTB/POZ domain-containing protein
01

Overview

Kelch-like protein 28 (KLHL28) is a soluble, cytoplasmic adaptor protein encoded by the KLHL28 gene. It belongs to the larger kelch-like protein family, characterized by a conserved set of motifs: BTB/POZ domain (protein binding/dimerization), a BACK domain (putative structural importance), and multiple kelch domains forming a β-propeller fold[1][3]. KLHL28 is broadly expressed, with elevated levels in brain and heart tissue, and interacts with numerous proteins forming part of the E3 ubiquitin ligase complex—most prominently Cullin-3 (CUL3)[1]. This complex is critical for protein turnover via ubiquitin-mediated degradation. KLHL28 dysregulation has been linked in genomic studies to increased risk of cancer, hypertension, and epilepsy[1][2][3]. Unlike classical receptors or enzymes targeted by drugs, KLHL28 serves mostly as a substrate adaptor within protein degradation pathways. Its clinical significance is largely based on its genetic, molecular, or functional involvement in disease states rather than as a direct therapeutic target[1][2][3].

Other names
Kelch-like family member 28KLHL28BTBD5FLJ20081BTB/POZ domain-containing protein 5kelch-like 28
02

Biological functions

Protein ubiquitination/targeting for degradationProtein-protein interaction (assembly of E3 ligase complexes)Cytoskeletal organization and cell morphology (inferred from related kelch proteins)Ubiquitin-dependent proteasomal protein catabolic process
03

Disease associations

Cancer (dysregulation associated with increased risk)Hypertension and hyperkalemia (aberrant activation)Epilepsy, juvenile myoclonic epilepsy (gene association)

Beyond the preview

Go deeper on Kelch-like protein 28 (KLHL28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kelch-like protein 28 (KLHL28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call